| BNP PARIBAS JAPAN EQUITY I CAP | RVI JAPÓN | 40,77% | 78,68% | 84,83% | 164,69% |
| CANDRIAM EQUITIES L EMERGING MARKETS I CAP EUR | RVI EMERGENTES | 56,01% | 92,52% | 38,12% | 164,65% |
| ABRDN SICAV I-FUTURE MINERALS FUND A ACC EUR | RVI MATERIAS PRIMAS | 56,64% | 50,23% | 63,46% | 164,64% |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI B EUR ACC | RVI EMERGENTES | 46,92% | 91,56% | 64,15% | 164,58% |
| AB SICAV I-GLOBAL VALUE PORTFOLIO S1 GBP | RVI GLOBAL VALOR | 31,57% | 62,39% | 69,73% | 164,51% |
| SCHRODER ISF US SMALLER COMPANIES IMPACT C ACC USD | RVI USA SMALL/MID CAP | 30,79% | 45,06% | 44,40% | 164,45% |
| T.ROWE ASIAN OPPORTUNITIES EQUITY FUND A | RVI ASIA PACÍFICO | 50,85% | 67,46% | 32,31% | 164,35% |
| SCHRODER GAIA EGERTON EQUITY C ACC USD (HEDGED) | RENT. ABSOLUTA. | 9,56% | 58,53% | 67,55% | 164,29% |
| ROBECO BP US LARGE CAP EQUITIES FH EUR | RVI USA | 27,47% | 62,97% | 62,28% | 164,27% |
| PICTET - BIOTECH P EUR | RVI BIOTECNOLOGÍA | 83,50% | 82,71% | 59,20% | 164,25% |
| ROBECO BP US SELECT OPPORTUNITIES EQUITIES F EUR | RVI USA SMALL/MID CAP | 18,54% | 38,42% | 57,55% | 164,16% |
| DPAM B EQUITIES EUROPE SUSTAINABLE F EUR CAP | RVI EUROPA | 13,94% | 29,94% | 31,68% | 164,14% |
| XTRACKERS MSCI EUROPE ESG SCREENED UCITS ETF 1C | RVI EUROPA | 19,37% | 46,99% | 53,18% | 164,14% |
| ING DIRECT FONDO NARANJA EURO STOXX 50, FI | RV EURO | 18,52% | 50,18% | 66,20% | 164,12% |
| BGF EMERGING MARKETS EQUITY INCOME I2 CHF (HEDGED) | RVI EMERGENTES | 48,58% | 81,37% | 56,01% | 164,09% |
| SEILERN INTERNATIONAL FUNDS PLC - SEILERN AMERICA USD U I | RVI USA | -9,32% | -3,25% | 1,74% | 164,08% |
| PICTET - BIOTECH P DY USD | RVI BIOTECNOLOGÍA | 83,18% | 83,93% | 59,23% | 164,06% |
| UBS (LUX) SECURITY EQUITY (CHF HEDGED) P-ACC | RVI OTROS SECTORES | -1,02% | 30,80% | 29,07% | 164,06% |
| PICTET - BIOTECH P USD | RVI BIOTECNOLOGÍA | 83,18% | 83,93% | 59,23% | 164,03% |
| BGF EUROPEAN EQUITY TRANSITION A2 USD (HEDGED) | RVI EUROPA | 21,55% | 36,60% | 47,39% | 163,95% |
